(AWARD-6) 3 A 26-week, randomized, open-label, parallel-group, multicenter (62 sites), multinational (9 countries), phase 3, noninferiority study
Major cardiovascular outcomes trials such as SUSTAIN-6 and PIONEER-6 included patients with various comorbidities, but did not specifically report outcomes in autoimmune disease subgroups, representing a knowledge gap in this area
CL Answer Does Neuriva improve memory or cognitive function
Some people who take GLP-1s report experiencing certain side effects, particularly gastrointestinal symptoms including nausea, vomiting, diarrhea and constipation
Sourcing, purity verification, proper storage, and protocol design matter just as much as the compound sitting inside the vial
GLP-1s can promote the production of insulin in patients and were originally designed to treat diabetes